mirikizumab-mrkz
mirikizumab-mrkz is listed in the FDA National Drug Code directory with 14 NDC codes, marketed under brand name including Omvoh. Available dosage forms: injection, solution, kit.
Drug Details
- Generic Name
- mirikizumab-mrkz
- Brand Names
- Omvoh
- Application Number
- BLA761279
- Sponsor
- Eli Lilly and Company
- NDC Codes
- 14
- Dosage Forms
- INJECTION, SOLUTION, KIT
- Routes
- SUBCUTANEOUS, INTRAVENOUS
- Active Ingredients
- MIRIKIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE OMVOH is indicated for the treatment of: moderately to severely active ulcerative colitis in adults. moderately to severely active Crohn's disease in adults. OMVOH TM is an interleukin-23 antagonist indicated for the treatment of: moderately to severely active ulcerative colitis in adults ( 1 ) moderately to severely active Crohn's disease in adults ( 1 )